{
     "PMID": "26965653",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20180104",
     "LR": "20180104",
     "IS": "1090-2139 (Electronic) 0889-1591 (Linking)",
     "VI": "56",
     "DP": "2016 Aug",
     "TI": "Indoleamine-2,3-dioxygenase mediates neurobehavioral alterations induced by an intracerebroventricular injection of amyloid-beta1-42 peptide in mice.",
     "PG": "363-77",
     "LID": "10.1016/j.bbi.2016.03.002 [doi] S0889-1591(16)30047-2 [pii]",
     "AB": "Alzheimer's disease (AD) is a neurodegenerative disorder that is characterized by a progressive cognitive decline along with various neuropsychiatric symptoms, including depression and anxiety. Increasing evidence has been proposed the activation of the tryptophan-degrading indoleamine-2,3-dyoxigenase (IDO), the rate-limiting enzyme of kynurerine pathway (KP), as a pathogenic factor of amyloid-beta (Abeta)-related inflammation in AD. In the current study, the effects of an intracerebroventricular (i.c.v.) injection of Abeta1-42 peptide (400pmol/mice; 3mul/site) on the regulation of KP biomarkers (IDO activity, tryptophan and kynurerine levels) and the impact of Abeta1-42 on neurotrophic factors levels were investigated as potential mechanisms linking neuroinflammation to cognitive/emotional disturbances in mice. Our results demonstrated that Abeta1-42 induced memory impairment in the object recognition test. Abeta1-42 also induced emotional alterations, such as depressive and anxiety-like behaviors, as evaluated in the tail suspension and elevated-plus maze tests, respectively. We observed an increase in levels of proinflammatory cytokines in the Abeta1-42-treated mice, which led to an increase in IDO activity in the prefrontal cortex (PFC) and the hippocampus (HC). The IDO activation subsequently increased kynurerine production and the kynurenine/tryptophan ratio and decreased the levels of neurotrophic factors in the PFC and HC, which contributed to Abeta-associated behavioral disturbances. The inhibition of IDO activation by IDO inhibitor 1-methyltryptophan (1-MT), prevented the development of behavioral and neurochemical alterations. These data demonstrate that brain IDO activation plays a key role in mediating the memory and emotional disturbances in an experimental model based on Abeta-induced neuroinflammation.",
     "CI": [
          "Copyright (c) 2016 Elsevier Inc. All rights reserved."
     ],
     "FAU": [
          "Souza, Leandro Cattelan",
          "Jesse, Cristiano R",
          "Antunes, Michelle S",
          "Ruff, Jossana Rodrigues",
          "de Oliveira Espinosa, Dieniffer",
          "Gomes, Nathalie Savedra",
          "Donato, Franciele",
          "Giacomeli, Renata",
          "Boeira, Silvana Peterini"
     ],
     "AU": [
          "Souza LC",
          "Jesse CR",
          "Antunes MS",
          "Ruff JR",
          "de Oliveira Espinosa D",
          "Gomes NS",
          "Donato F",
          "Giacomeli R",
          "Boeira SP"
     ],
     "AD": "Laboratorio de Avaliacoes Farmacologicas e Toxicologicas Aplicadas as Moleculas Bioativas, LaftamBio Pampa, Universidade Federal do Pampa, Itaqui, RS, Brazil. Laboratorio de Avaliacoes Farmacologicas e Toxicologicas Aplicadas as Moleculas Bioativas, LaftamBio Pampa, Universidade Federal do Pampa, Itaqui, RS, Brazil. Electronic address: cristianoricardojesse@yahoo.com.br. Laboratorio de Avaliacoes Farmacologicas e Toxicologicas Aplicadas as Moleculas Bioativas, LaftamBio Pampa, Universidade Federal do Pampa, Itaqui, RS, Brazil. Laboratorio de Avaliacoes Farmacologicas e Toxicologicas Aplicadas as Moleculas Bioativas, LaftamBio Pampa, Universidade Federal do Pampa, Itaqui, RS, Brazil. Laboratorio de Avaliacoes Farmacologicas e Toxicologicas Aplicadas as Moleculas Bioativas, LaftamBio Pampa, Universidade Federal do Pampa, Itaqui, RS, Brazil. Laboratorio de Avaliacoes Farmacologicas e Toxicologicas Aplicadas as Moleculas Bioativas, LaftamBio Pampa, Universidade Federal do Pampa, Itaqui, RS, Brazil. Laboratorio de Avaliacoes Farmacologicas e Toxicologicas Aplicadas as Moleculas Bioativas, LaftamBio Pampa, Universidade Federal do Pampa, Itaqui, RS, Brazil. Laboratorio de Avaliacoes Farmacologicas e Toxicologicas Aplicadas as Moleculas Bioativas, LaftamBio Pampa, Universidade Federal do Pampa, Itaqui, RS, Brazil. Laboratorio de Avaliacoes Farmacologicas e Toxicologicas Aplicadas as Moleculas Bioativas, LaftamBio Pampa, Universidade Federal do Pampa, Itaqui, RS, Brazil.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article"
     ],
     "DEP": "20160307",
     "PL": "Netherlands",
     "TA": "Brain Behav Immun",
     "JT": "Brain, behavior, and immunity",
     "JID": "8800478",
     "RN": [
          "0 (Amyloid beta-Peptides)",
          "0 (Indoleamine-Pyrrole 2,3,-Dioxygenase)",
          "0 (Nerve Growth Factors)",
          "0 (Peptide Fragments)",
          "0 (amyloid beta-protein (1-42))",
          "343-65-7 (Kynurenine)",
          "8DUH1N11BX (Tryptophan)"
     ],
     "SB": "IM",
     "MH": [
          "Amyloid beta-Peptides/administration & dosage/*pharmacology",
          "Animals",
          "Anxiety/*chemically induced",
          "Behavior, Animal/*drug effects",
          "Depression/*chemically induced",
          "Disease Models, Animal",
          "Hippocampus/*drug effects",
          "Indoleamine-Pyrrole 2,3,-Dioxygenase/drug effects/*metabolism",
          "Inflammation/*chemically induced",
          "Injections, Intraventricular",
          "Kynurenine/*drug effects",
          "Memory Disorders/*chemically induced",
          "Mice",
          "Nerve Growth Factors/*drug effects",
          "Peptide Fragments/administration & dosage/*pharmacology",
          "Prefrontal Cortex/*drug effects",
          "Recognition (Psychology)/drug effects",
          "Tryptophan/*drug effects"
     ],
     "OTO": [
          "NOTNLM"
     ],
     "OT": [
          "Alzheimer's disease",
          "Anxiety",
          "Depression",
          "Indoleamine-2,3-dyoxigenase",
          "Kynurerine",
          "Memory",
          "Neuroinflammation",
          "Neurotrophic factor",
          "Tryptophan"
     ],
     "EDAT": "2016/03/12 06:00",
     "MHDA": "2018/01/05 06:00",
     "CRDT": [
          "2016/03/12 06:00"
     ],
     "PHST": [
          "2015/11/07 00:00 [received]",
          "2016/03/06 00:00 [revised]",
          "2016/03/07 00:00 [accepted]",
          "2016/03/12 06:00 [entrez]",
          "2016/03/12 06:00 [pubmed]",
          "2018/01/05 06:00 [medline]"
     ],
     "AID": [
          "S0889-1591(16)30047-2 [pii]",
          "10.1016/j.bbi.2016.03.002 [doi]"
     ],
     "PST": "ppublish",
     "SO": "Brain Behav Immun. 2016 Aug;56:363-77. doi: 10.1016/j.bbi.2016.03.002. Epub 2016 Mar 7.",
     "term": "hippocampus"
}